Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, United States of America.
Department of Clinical Studies/New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, United States of America.
PLoS One. 2020 Dec 10;15(12):e0232920. doi: 10.1371/journal.pone.0232920. eCollection 2020.
Supporting Limb Laminitis (SLL) is a painful and crippling secondary complication of orthopedic injuries and infections in horses, often resulting in euthanasia. SLL causes structural alterations and inflammation of the interdigitating layers of specialized epidermal and dermal tissues, the lamellae, which suspend the equine distal phalanx from the hoof capsule. Activation of the interleukin-17A (IL-17A)-dependent inflammatory pathway is an epidermal stress response that contributes to physiologic cutaneous wound healing as well as pathological skin conditions. As a first test of the hypothesis that hoof lamellae of horses diagnosed with SLL also respond to stress by activating the IL-17A pathway, the expression of IL-17A, IL-17 receptor subunit A and 11 IL-17A effector genes was measured by RT-PCR or qPCR. Lamellar tissue was isolated from Thoroughbreds euthanized due to naturally occurring SLL and in age and breed matched non-laminitic controls. By RT-PCR, the IL-17 Receptor A subunit was expressed in both non-laminitic and laminitic tissues, while IL-17A was primarily detectable in laminitic tissues. IL-17A target gene expression was undetectable in non-laminitic samples with the exception of weak detection of DEFB4B, S100A9 and PTSG2. In contrast, all target genes examined, except CCL20, were expressed by some or all laminitic samples. By qPCR, severe acute (n = 7) SLL expressed ~15-100 fold higher levels of DEFB4B and S100A9 genes compared to non-laminitic controls (n = 8). DEFB4B was also upregulated in developmental/subclinical (n = 8) and moderate acute (n = 7) by ~ 5-fold, and in severe chronic (n = 5) by ~15-200 fold. In situ hybridization (DEFB4) and immunofluorescence (calprotectin, a dimer of S100A9/S100A8 proteins) demonstrated expression in keratinocytes, primarily in suprabasal cell layers, from SLL samples. These data demonstrate upregulation of a cohort of IL-17A target genes in SLL and support the hypothesis that similarities in the response to stresses and damage exist between equine and human epidermal tissues.
支持性蹄叶炎(SLL)是马的骨科损伤和感染的一种痛苦且致残的继发性并发症,常导致安乐死。SLL 导致专门的表皮和真皮组织的层状结构发生改变和炎症,即悬蹄的鳞片,从蹄壳悬挂马的远节趾骨。白细胞介素-17A(IL-17A)依赖性炎症途径的激活是表皮应激反应,有助于生理性皮肤伤口愈合以及病理性皮肤状况。作为 SLL 诊断的马蹄鳞片也通过激活 IL-17A 途径对应激做出反应的假设的第一个测试,通过 RT-PCR 或 qPCR 测量了 IL-17A、IL-17 受体亚单位 A 和 11 个 IL-17A 效应基因的表达。从因自然发生的 SLL 而安乐死的纯种马和年龄和品种匹配的非蹄叶炎对照中分离出鳞片组织。通过 RT-PCR,IL-17 受体 A 亚基在非蹄叶炎和蹄叶炎组织中均有表达,而 IL-17A 主要在蹄叶炎组织中检测到。除了 DEFB4B、S100A9 和 PTSG2 的微弱检测外,非蹄叶炎样本中无法检测到 IL-17A 靶基因的表达。相比之下,所有检查的靶基因,除了 CCL20,都被一些或所有蹄叶炎样本表达。通过 qPCR,严重急性(n = 7)SLL 与非蹄叶炎对照(n = 8)相比,DEFB4B 和 S100A9 基因表达水平高出约 15-100 倍。在发育性/亚临床(n = 8)和中度急性(n = 7)中,DEFB4B 也上调了约 5 倍,在严重慢性(n = 5)中上调了约 15-200 倍。原位杂交(DEFB4)和免疫荧光(钙卫蛋白,S100A9/S100A8 蛋白的二聚体)显示 SLL 样本中的角蛋白细胞中表达,主要在上皮细胞的基底上层。这些数据表明 SLL 中一组 IL-17A 靶基因的上调,并支持这样的假设,即马和人类表皮组织对应激和损伤的反应存在相似性。